Vice President of Digital Business Development & Licensing, Sanofi
Rachel Sha is the Vice President of Digital Business Development & Licensing at Sanofi. She leads a team of business development professionals in driving transactions from identifying new opportunities to deal closing across therapeutic areas and use cases in digital health with the goal of discovering, developing, and bringing to market solutions that improve outcomes, experience, at reduced costs. Companies she has led partnering deals with in digital include Science 37 which enables decentralized clinical studies and Evidation Health, a leader in behavior analytics. She co-led the transaction with Verily Life Sciences in diabetes and was the alliance manager to the collaboration with Verily Life Sciences and led the formation of the joint venture called Onduo.
She joined Genzyme in 2005 and has held roles of increasing responsibility in Business Development, Corporate Development, and Global Marketing & Strategy for Genzyme and Sanofi. Prior to Sanofi, Genzyme, Rachel was a manager at Accenture where she focused on a broad range of business issues from strategy to process to technology implementation across a diverse set of industries with focus in electronics & high tech in particular. Rachel holds a BS from Massachusetts Institute of Technology in Chemistry and an MBA from Harvard Business School.